FDA OKs Cerus trial of Intercept blood device for Ebola patients

The FDA OKs Cerus Corp.'s Intercept blood system in processing plasma from Ebola survivors as a possible treatment for the deadly virus.

Cerus Corp., Food & Drug Administration (FDA)

News Well, Investigational Device Exemption (IDE), Ebola

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ygC7FS